[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Life Sciences Market Research Reports & Industry Analysis

“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.

The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.

A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.

Publications found: 190,923
Sort by:
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 US$ 3,495.00

... the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies REPORT SCOPE Global Asset Purchase Deals in Pharma, Biotech and ...

April 2020 600 pages
Global Cardiovascular Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... heart failure, Coronary artery disease, Ductus arteriosus, Fatigue, Hypercholesterolemia, Hypertension, Intermittent claudication, Ischemic heart disease, Limb ischemia, Marfan's Syndrome, Myocardial Infarction, Oedema (excess fluid), Palpitations, Peripheral arterial disease, Thrombus (blood clot), Valvular ...

April 2020 450 pages
Global Central Nervous System Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... Cerebral palsy, Creutzfeldt Jakob disease, Dizziness, Epilepsy, Faints, Falls, Guillain Barre syndrome, Headache, Meningitis (Bacterial, Meningococcal, Pneumococcal), Mycobacterium tuberculosis (TB), Haemophilus influenzae Type B (Hib), Migraine, Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig ...

April 2020 850 pages
Global Dental Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Dental Partnering 2014 to 2019 provides the full collection of Dental disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Dental partnering deals Financial deal terms ...

April 2020 200 pages
Global Gastrointestinal Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... , Esophagitis, Gastritis, Gastroenteritis, Hemorrhoids (haemorrhoids), Hernia, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Irritable bowel syndrome, Malabsorption, Malnutrition, Pancreatitis, Peptic ulce, Gastric ulcer, Duodenal ulcer, Abdominal pain, Ascites, Bowel movement, Constipation ...

April 2020 300 pages
Global Dermatology Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles ...

April 2020 350 pages
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 US$ 3,495.00

... manufacturing and supply deals by value since 2014 Most active manufacturing and supply dealmakers since 2014 The leading manufacturing and supply partnering resources In Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech ...

April 2020 950 pages
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020 US$ 3,495.00

... Current Agreements deals and alliances database, providing easy access to each deal record on demand. The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 ...

April 2020 250 pages
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 US$ 3,495.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

April 2020 400 pages
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020 US$ 3,495.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

April 2020 2500 pages
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 US$ 3,495.00

... DESCRIPTION The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and ...

April 2020 1000 pages
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 US$ 3,495.00

... Joint venture alliances. KEY BENEFITS Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 provides the reader with the following key benefits: In-depth understanding of joint venture partnering deal ...

April 2020 300 pages
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 US$ 3,495.00

... latest licensing agreements announced in the pharmaceutical, biotechnology ... licensing deals by value since 2014 Most active licensing dealmakers since 2014 The leading licensing partnering resources In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals ...

April 2020 2000 pages
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 US$ 3,495.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

April 2020 750 pages
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2020 US$ 3,495.00

... including the technology licensed, royalty rates, license fees, upfront and milestone payments. DESCRIPTION The Global Royalty Rate Trends in Pharma ... licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate ...

April 2020 400 pages
Global Autoimmune Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... autoimmune diseases: Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis, Glomerulonephritis, Endometriosis, Immune thrombocytopenic purpura, Neutropenia, Graft versus host disease, Scleroderma ...

April 2020 600 pages
2020 Argentina Tumor Markers Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Asia-Pacific Tumor Markers Sales Segment Forecasts: A 17-Country Analysis-Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 14,500.00

This new 17-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as we...

April 2020 1450 pages
2020 Australia Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Austria Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Bahrain Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Bangladesh Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Belgium Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Brazil Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Bulgaria Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Canada Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Chile Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 China Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Colombia Republic Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Croatia Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Cyprus Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Czech Republic Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Denmark Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Egypt Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Estonia Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Europe Tumor Markers Sales Segment Forecasts: A 31-Country Analysis-Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 35,000.00

This new 31-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as we...

April 2020 935 pages
2020 Europe Tumor Markers Sales Segment Forecasts: France, Germany, Italy, Spain, UK-Supplier Shares and Strategies, Emerging Tests and Technologies US$ 19,700.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in major...

April 2020 820 pages
2020 Finland Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 France Tumor Markers Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 4,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the Fre...

April 2020 585 pages
2020 Germany Tumor Markers Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 4,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the German cancer diagnostics market during the next five years. The report examines trends in the Ger...

April 2020 585 pages
2020 Ghana Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Global Tumor Markers Sales Segment Forecasts: US, Europe, Japan-Supplier Shares and Strategies, Emerging Tests and Technologies US$ 28,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S...

April 2020 1200 pages
2020 Greece Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Hong Kong Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Hungary Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Iceland Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 India Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Indonesia Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Iran Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages
2020 Iraq Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities US$ 3,500.00

This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examin...

April 2020 535 pages

Filters

Clear all

Search

Categories

18
843
409
240
44
20,194
391
5,708
258
863
716
677
52
84
957
4
527
238
555
583
543
26
187
40
13,513
87
31
170
487
666
48
174
119
298
97
2,115
160
45
836
116
1,228
737
542
1,788
4,216
1,364
89
72,880
543
54,321
96

Publishers

188
21
1,083
254
698
53
1
15,082
3,637
375
2,012
142
1
2,189
4
1
262
61
2
192
9
1,696
8
29
72
93
204
3
15
2
15
7,740
270
532
5
4,946
6,550
171
1,102
1
321
1
118
1
32,081
484
3
66
5
5
214
2
1,360
11,312
160
56
71
481
149
148
214
7,384
2,684
3
4
536
114
15
23
3
107
22
21,448
31
31
1
16
89
9,623
54
105
1
562
1
1,261
2,136
48
220
27
5
11,235
2
45
3
173
10
71
5
286
11
17
21
112
258
36
25
3
436
2
4
89
18
186
8
308
5
3
48
3
379
118
58
53
59
8
20
85
96
1
2
9
1
868
1
13
7
5
494
1
1
28
139
15
1
1
31
2
3
26
7
3
2
1
121
7
1
305
6
258
3
167
47
22,388
128
1
2
4
114
2
16
9
43
248
26
1
213
3
9
4
22
1
5
104
3,774
1
2
3
217
400
78
689
845
388
174
160
8
47
32
270
38
4
44

Regions

133
82
78
78
63
62
62
62
39
19
18
18
17
15
15
11
9
6
5
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1,608
1,510
1,399
1,349
1,344
1,339
372
363
356
299
176
166
165
161
161
161
155
153
153
152
151
151
147
146
145
141
140
139
137
134
130
129
128
124
124
124
121
121
118
116
110
95
89
87
83
68
65
61
51
49
45
35
28
22
13
26
116
39
124
31
6,259
354
333
154
7,093
3,579
286
191
132,002
74
57
58
343
321
155
153
151
110
26
47
32
46
28
26
1
1
119
99
97
97
35
26
9
76
107
5,021
4,642
4,261
7,870

Price

—

Date

—

Pages

—

Offers

62
1
4
7
5